Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

1 hr ago | Bloomberg

Bristol-Myers Tops Earnings Estimates on Drug Sales

Bristol-Myers Squibb Co. , the maker of the anti-psychotic drug Abilify, reported second-quarter profit that topped analysts' estimates on sales of its cancer medicine Yervoy and blood thinner Eliquis.


Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Hepatitis, Health, US News

5 hrs ago | American Reporter

One Woman's WorldLIFE Can Become Too Quiet

The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.


Related Topix: Financial Markets, Personal Finance, Retirement, Microsoft, Startups, Biotech, Medicine, Healthcare Industry

Wed Jul 23, 2014

Seeking Alpha

Today's Market: Biotech Names Rallying Today

Our regular readers know that we have been using the idea of buying on the dips and searching for value while investing in this bull market the past few years.


Related Topix: Biotech, Science / Technology, Medicine, Pfizer, Excaliard Pharmaceuticals, Healthcare Industry, Foldrx Pharmaceuticals

Daily Record

Prempro lawyers agree to settle $62 million fee fight

Lawyers who battled Pfizer Inc. for more than a decade over women's cancers linked to the company's Prempro menopause drug settled a rare public dispute over $62 million in fees.


Related Topix: Medicine, Prempro, Estrogen/Progestin (generic), Biotech, Healthcare Industry, Cancer, Health, Menopause, Breast Cancer, Arkansas

Seeking Alpha

Too Early To Tell For Atara Biotherapeutics IPO

ATRA, a clinical-stage biopharmaceutical firm, engaged in the development of treatments for muscle wasting conditions, plans to raise $75.0 million in its upcoming IPO.


Related Topix: Venture Capital, Emerging Technology, San Mateo County, CA, Brisbane, CA, Biotech, Medicine, Amgen, Healthcare Industry

Wednesday's ETF with Unusual Volume: PPH

The Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday, with over 377,000 shares traded versus three month average volume of about 101,000.


Related Topix: Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Financial Markets


Puma Biotechnolgy Triples on Trial Data, Still Room to Run?

Although we did not see a positive neratinib ExteNET outcome in adjuvant breast cancer as a complete surprise, we believe the magnitude of benefit is among best-case scenarios that could be envisioned.


Related Topix: Healthcare Law, Law, Medicine, Breast Cancer, Biotech, Healthcare Industry


Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials

July 23, 2014 By Renee Morad , Breaking News Staff Puma Biotechnology Inc. announced an amendment to its licensing agreement with Pfizer regarding its investigational cancer drug neratinib, or PB272.


Related Topix: Biotech, Medicine, Healthcare Industry, Startups,, Media, Fox Filmed Entertainment

Pfizer: A Fairly Valued Stock

In a previous article we saw that Pfizer Inc. was the principal holding in Zacks Investment ManagementA s Portfolio.


Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 22, 2014


UPDATE 1-Puma says cancer drug meets trial goal, shares soar

Shares of the company, which doesn't have any drug in the market, tripled to $176.94 in extended trading.


Related Topix: Medicine, Health, Breast Cancer, Biotech, Healthcare Industry, Lung Cancer

Fox News

FT: 25 More Firms May Seek Tax Breaks Overseas

A top Democrat warned on Tuesday a recent string of so-called tax inversions could foreshadow future moves as U.S. firms look to dodge American taxes.


Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech, Business News

No Need To Envy Tax-Inversion Takeovers: Better Tax Deal Awaits

Watching big pharmaceutical companies and other major U.S. corporations line up to make foreign acquisitions that will bring them a low-tax haven as headquarters, a middle market CEO/owner/entrepreneur could easily become jealous.


Related Topix: Walgreens, Retail, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech

Pfizer Given Average Rating of "Buy" by Analysts

Shares of Pfizer have received a consensus rating of "Buy" from the seventeen ratings firms that are covering the company, Stock Ratings Network reports .


Related Topix: Biotech, Medicine, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services

Mon Jul 21, 2014


Dow Analyst Moves: PFE

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Pfizer is the #16 analyst pick.


Related Topix: Financial Markets, Biotech, Medicine, Healthcare Industry, Business News, Video

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .


Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

Although This Hedge Fund Changed Stocks in Three of Them Bet More

Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission .


Related Topix: Corporate / Securities Law, Law, Securities and Exchange Commission, Biotech, Medicine, Healthcare Industry, Exxon Mobil, Oil & Gas, Energy, Chevron Corporation, Banking, Wells Fargo , Financial Services, Mortgage, Personal Finance

Fri Jul 18, 2014

The Independent

US drugs giant finally seals A 32bn takeover of Shire

Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.


Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry

Judge finds Pfizer responsible for $1.72M in sewer payments

The Borough of West Chester early this week won the latest episode in a years-long court battle with drugmaker Pfizer over sewer payments owed to the borough by Wyeth, the pharmaceutical company that Pfizer bought in 2009 for $68 billion.


Related Topix: Biotech, Medicine, Healthcare Industry, West Chester, PA

Fox News

Will Congress Scuttle the AbbVie-Shire Merger?

AbbVie's $54 billion proposal to acquire Irish drug maker Shire would mark the largest tax inversion ever, as a growing number of U.S. companies pursue lower rates overseas.


Related Topix: US News, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Abbott Laboratories, Medtronic, Medical Equipment, Orrin Hatch, US Senate, Republican, US Politics

Thu Jul 17, 2014

Value Line

Drug Roundup - July 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.


Related Topix: Biotech, Medicine, Healthcare Industry, Merck , Eli Lilly, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Pharmaceuticals


Ashburn Jobs